About us


PinCell is a biotech company founded in October 2008 as an academic spin-off of the University of Modena and Reggio Emilia by initiative of Prof. Carlo Pincelli and Dr. Alessandra Marconi.

The Mission is to research and develop novel molecules that will increase the therapeutic options for neoplastic and chronic inflammatory skin diseases.

  • The research and development process is focused on drug discovery, drug physico-chemical characterization, preclinical pharmacology and toxicology studies and early phase clinical trials on healthy volunteers (phase I)

  • PinCell directs its discoveries to other biotechnological companies or to pharmaceutical industries in need for novel ideas for drug development or looking for products at advanced stage of development requiring rapid commercial transfer.

Subpages (2): Management Mission